Zuellig Pharma, one of the largest healthcare services groups in Asia, has acquired Singapore-based healthtech startup Klinify while AI-based outsourcing provider Supahands raised an undisclosed amount of series A funding led by Patamar Capital.
Zuellig Pharma acquires Singapore-based healthcare startup
Healthcare services provider Zuellig Pharma has acquired Singapore-based healthtech startup Klinify to enable doctors streamline their workflows, according to an announcement.
Klinify is a cloud-based digital medical assistant used by over 800 doctors in Malaysia to manage their clinics more efficiently.
“Utilising innovative technology can drive efficiencies to provide better access to healthcare. Klinify helps doctors deliver better care and business through the efficient digitisation of medical information,” said Maarten Kelder, SVP Strategy and Corporate Development at Zuellig Pharma.
Zuellig Pharma is building a digital platform to connect the healthcare ecosystem in Asia. Zuellig Pharma is one of the largest healthcare services groups in Asia. The company was started almost a hundred years ago and has grown to become a $13 billion business covering 13 markets with over 10,000 employees.
Supahands bags Series A investment from Patamar Capital, Cradle Seed Ventures
Supahands, an AI-based outsourcing provider, has raised an undisclosed amount of series A funding led by South and Southeast Asia-focused venture capital firm Patamar Capital, the company said in a statement on Monday.
A venture capital arm of Malaysia-based Cradle Fund, Cradle Seed Ventures, also participated in the funding round.
The new investment will be used for the company’s expansion in the Asia Pacific.
Founded in 2014 in Malaysia, Supahands connects clients using its AI-machine learning with the workers in several countries in Southeast Asia.
The company previously secured seed funding from 500 Startups, Axiata Digital Innovation Fund, as well as Cradle Seed Ventures.
Supahands appointed two new board members into its company, Shuyin Tang, a partner at Patamar Capital, and Nor Azah Razali, a senior advisor and former partner, and managing director at Boston Consulting Group.